行情中心升级到1.1版! 官方博客

基金业绩

基金费率

投资组合

基金概况

财务数据

华宝医药生物混合A(240020)

2024-03-18     2.56001.6276%
收入分析
单位:万元
报告期 证券买卖差价收入 投资收益 回购收入 其他收入 合计
2023-06-300.000.000.000.00209.20
2022-12-310.000.004.810.00-15,985.00
2022-06-300.000.004.810.00-10,937.60
2021-12-310.000.000.000.009,366.52
2021-06-300.000.000.000.0017,051.92
2020-12-310.000.000.000.0048,301.93
2020-06-300.000.000.000.0039,789.39
2019-12-310.000.0030.680.0022,596.72
2019-06-300.000.0028.930.0012,022.42
2018-12-310.000.0043.170.00-6,099.78
2018-06-300.000.005.250.005,381.16
2017-12-310.000.0017.510.008,881.77
2017-06-300.000.000.000.005,731.87
2016-12-310.000.001.060.00-16,651.97
2016-06-300.000.001.060.00-17,105.90
2015-12-310.000.000.000.0040,251.42
2015-06-300.000.000.000.0048,923.97
2014-12-310.000.006.940.006,551.61
2014-06-300.000.000.000.002,967.22
2013-12-310.000.003.110.009,942.86
2013-06-300.000.000.000.004,979.08
2012-12-310.000.0029.350.003,796.67
2012-06-300.000.0029.350.002,484.32